HEV239
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HEV239, covering 2021-09-24 to 2021-09-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Hepatitis E Vaccine (HEV239) [Phase 1]